Glucose levels significantly enhanced leptin effects on MetALD risk, with the interaction term indicating that hyperglycemia potentiated leptin’s association with MetALD (RRR 1.98, 95% CI 1.04–3.79, p = 0.038), while effects on other SLD categories remained unmodified. The gene discussed is LEP; the disease is Hyperglycemia.